Medinet (2370) · InitiativeRestated
Mechanization, Efficiency and Standardization of the Immune Cell-Processing Process
First written in FY2017. 1 of 2 entries say "Restated". Latest entry: FY2019.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Automation of Cell Product Manufacturing Processes and Development of Production EquipmentA theme 3 companies write about · 0 as a headwind · 3 as a tailwind
1 other company's latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2019RestatedAnnual report
「In this business, the company improves cell processing technologies and develops various regenerative and cell medicine technologies. During the fiscal year, it conducted studies and other work aimed at improving the profitability of the immune cell processing process.」
The company continues to study technology improvements and profitability enhancement for the immune cell processing process. - FY2017First statedAnnual report
「As part of the development of technology to improve the efficiency and standardization of immune cell processing, we are considering introducing mechanization and examining whether the technology developed can be adopted in the immune cell-processing process to improve its efficiency.」
The Company is pursuing mechanization and process efficiency and standardization as R&D themes for immune cell processing.